Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isak W Tengesdal

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cell|May 2, 2025
Mutant macrophages CHIP in to help solid tumorsIsak W Tengesdal, Siddhartha Jaiswal
Annual Review of Pathology|September 10, 2025
Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated Immune Cells by Clonal Hematopoiesis in the Diseased TissueYoungil Koh, Isak W Tengesdal, Siddhartha Jaiswal
Pharmacology & Therapeutics|October 22, 2023
NLRP3 and cancer: Pathogenesis and therapeutic opportunitiesIsak W Tengesdal, Charles A Dinarello, Carlo Marchetti
Frontiers in Immunology|August 27, 2024
Screening NLRP3 drug candidates in clinical development: lessons from existing and emerging technologiesIsak W Tengesdal, Migachelle Banks, Charles A Dinarello, et al.
Cells|January 21, 2023
Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 FunctionsAlberto Dinarello, Taylor S Mills, Isak W Tengesdal, et al.
Frontiers in Immunology|September 17, 2021
Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated ImmunosuppressionIsak W Tengesdal, Alberto Dinarello, Nicholas E Powers, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast CancersIsak W Tengesdal, Suzhao Li, Nicholas E Powers, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2019
Role for nuclear interleukin-37 in the suppression of innate immunitySuzhao Li, Jesus Amo-Aparicio, Charles P Neff, et al.
Arthritis Research & Therapy|August 5, 2018
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritisCarlo Marchetti, Benjamin Swartzwelter, Marije I Koenders, et al.
European Journal of Immunology|August 12, 2018
The selective ROCK2 inhibitor KD025 reduces IL-17 secretion in human peripheral blood mononuclear cells independent of IL-1 and IL-6Isak W Tengesdal, David Kitzenberg, Suzhao Li, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cell|May 2, 2025
Mutant macrophages CHIP in to help solid tumorsIsak W Tengesdal, Siddhartha Jaiswal
Annual Review of Pathology|September 10, 2025
Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated Immune Cells by Clonal Hematopoiesis in the Diseased TissueYoungil Koh, Isak W Tengesdal, Siddhartha Jaiswal
Pharmacology & Therapeutics|October 22, 2023
NLRP3 and cancer: Pathogenesis and therapeutic opportunitiesIsak W Tengesdal, Charles A Dinarello, Carlo Marchetti
Frontiers in Immunology|August 27, 2024
Screening NLRP3 drug candidates in clinical development: lessons from existing and emerging technologiesIsak W Tengesdal, Migachelle Banks, Charles A Dinarello, et al.
Cells|January 21, 2023
Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 FunctionsAlberto Dinarello, Taylor S Mills, Isak W Tengesdal, et al.
Frontiers in Immunology|September 17, 2021
Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated ImmunosuppressionIsak W Tengesdal, Alberto Dinarello, Nicholas E Powers, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast CancersIsak W Tengesdal, Suzhao Li, Nicholas E Powers, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2019
Role for nuclear interleukin-37 in the suppression of innate immunitySuzhao Li, Jesus Amo-Aparicio, Charles P Neff, et al.
Arthritis Research & Therapy|August 5, 2018
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritisCarlo Marchetti, Benjamin Swartzwelter, Marije I Koenders, et al.
European Journal of Immunology|August 12, 2018
The selective ROCK2 inhibitor KD025 reduces IL-17 secretion in human peripheral blood mononuclear cells independent of IL-1 and IL-6Isak W Tengesdal, David Kitzenberg, Suzhao Li, et al.
Pageof 2